XTX Topco Ltd Purchases Shares of 18,188 Astrana Health, Inc. (NASDAQ:ASTH)

XTX Topco Ltd purchased a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 18,188 shares of the company's stock, valued at approximately $564,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in ASTH. Quarry LP increased its position in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after purchasing an additional 471 shares during the last quarter. PharVision Advisers LLC purchased a new stake in Astrana Health in the 4th quarter worth approximately $211,000. Pictet Asset Management Holding SA lifted its position in shares of Astrana Health by 21.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock valued at $223,000 after acquiring an additional 1,273 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in Astrana Health by 19.9% during the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after buying an additional 1,184 shares in the last quarter. Finally, City Center Advisors LLC bought a new stake in Astrana Health in the first quarter worth $276,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

Astrana Health Stock Up 30.8%

Shares of Astrana Health stock traded up $6.62 during trading on Friday, hitting $28.08. 1,808,383 shares of the stock traded hands, compared to its average volume of 367,950. The firm has a market cap of $1.57 billion, a P/E ratio of 55.06, a price-to-earnings-growth ratio of 1.03 and a beta of 0.85. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.54. Astrana Health, Inc. has a 52-week low of $21.20 and a 52-week high of $63.20. The stock's fifty day simple moving average is $24.44 and its 200 day simple moving average is $29.14.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a net margin of 1.04% and a return on equity of 3.48%. The company had revenue of $654.81 million during the quarter, compared to analysts' expectations of $639.13 million. During the same quarter last year, the firm earned $0.40 EPS. Astrana Health's revenue for the quarter was up 34.7% on a year-over-year basis. On average, equities analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.